Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster or human cells susceptible to MHV infection

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 4142-4145

  Dveksler, Gabriela S ^a   Gagneten, Sara E ^a,c   Scanga, Charles A ^a,d   Cardellichio, Christine B ^a   Holmes, Kathryn V ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL SEQUENCE; ARTICLE; HAMSTER; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MURINE HEPATITIS CORONAVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION;

EID: 0029888103     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.4142-4145.1996     Document Type: Article

References (24)

1. Beauchemin, N., C. Turbide, D. Afar, J. Bell, M. Raymond, C. P. Stanners, and A. Fuks. 1989. A mouse analogue of the human carcinoembryonic antigen. Cancer Res. 49:2017-2021.
2. Byrn, R. A., I. Sekigawa, S. M. Chamow, J. S. Johnson, T. J. Gregory, D. J. Capon, and J. E. Groopman. 1989. Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4. J. Virol. 63: 4370-4375.
3. Casasnovas, J. M., and T. A. Springer. 1994. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J. Virol. 68:5882-5889.
4. 3a.Chen, D. S., M. Asanaka, K. Yokimori, F.-I. Wang, S. B. Hwang, H.-P. Li, and M. M. C. Lai. 1995. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA 92:12095-12099.
5. Clapham, P. R., J. N. Weber, D. Whitby, K. McIntosh, A. G. Dalgleish, P. J. Madden, K. C. Deen, R. W. Sweet, and R. A. Weiss. 1989. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (London) 337:368-370.
6. Deen, K. C., J. S. McDougal, R. Inacker, G. Wasserman, J. Arthos, J. Rosenberg, P. J. Maddon, R. Axel, and R. Sweet. 1988. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature (London) 331:82-84.
7. Dveksler, G. S., A. A. Basile, C. B. Cardellichio, and K. V. Holmes. 1995. Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain. J. Virol. 69:543-546.
8. Dveksler, G. S., C. W. Dieffenbach, C. B. Cardellichio, K. McCuaig, M. N. Pensiero, G.-S. Jiang, N. Beauchemin, and K. V. Holmes. 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1-8.
9. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G.-S. Jiang, K. V. Holmes, and C. W. Dieffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
10. Dveksler, G. S., M. N. Pensiero, C. W. Dieffenbach, C. B. Cardellichio, A. A. Basile, P. E. Elia, and K. V. Holmes. 1993. Mouse coronavirus MHV-A59 and blocking anti-receptor monoclonal antibody bind to the N-terminal domain of cellular receptor MHVR. Proc. Natl. Acad. Sci. USA 90:1715-1720.
11. Fuerst, T. R., E. G. Niles, W. F. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bactcriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8128.
12. Kaplan, G., M. S. Freistadt, and V. R. Racaniello. 1990. Neutralization of poliovirus by cell receptors expressed in insect cells. J. Virol. 64:4697-4702.
13. Marlin, S. D., D. E. Staunton, T. A. Springer, C. Stratowa, W. Sommerguber, and V. Merluzzi. 1990. A soluble form of intercellular adhesion molecule-l inhibits rhinovirus infection. Nature (London) 344:70-72.
14. MeInick, J., J. L. Dull, and Y. Argon. 1994. Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum. Nature (London) 370:373-375.
15. Nédellec, P., G. S. Dveksler, E. Daniels, C. Turbide, B. Chow, A. A. Basile, K. V. Holmes, and N. Beauchemin. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:4525-4537.
16. 14a.Obrink, B. Personal communication.
17. Rudert, F., A. M. Saunders, S. Rebstock, J. A. Thompson, and W. Zimmermann. 1992. Characterization of murine carcinoembryonic antigen gene family members. Mamm. Genome 3:262-273.
18. Smith, A. L., C. B. Cardellichio, D. F. Vinograd, M. S. deSouza, S. W. Barthold, and K. V. Holmes. 1991. Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits virus replication in vivo. J. Infect. Dis. 163:879-882.
19. Thompson, J. A. 1995. Molecular cloning and expression of carcinoembryonic antigen gene family members. Tumor Biol. 16:10-16.
20. Vallejo, A. N., R. J. Pogulis, and L. R. Pease. 1995. Mutagenesis and synthesis of novel recombinant genes using PCR, p. 603-612. In C. W. Dieffenbach and G. S. Dveksler (ed.), PCR primer. A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
21. Williams, A. F., and A. N. Barclay. 1988. The immunoglobulin superfamilydomains for cell surface recognition. Annu. Rev. Immunol. 6:381-405.
22. Williams, R. K., G.-S. Jiang, and K. V. Holmes. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
23. Yokomori, K., and M. M. C. Lai. 1992. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:6194-6199.
24. Yokomori, K., and M. M. C. Lai. 1992. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J. Virol. 66:6931-6938.